At the time of percutaneous transhepatic portal vein embolization (PVE), hyperbilirubinemia has no apparent effect on future liver remnant (FLR) hypertrophy, according to a new study. | Read More
In this video, Sean M. Tutton, MD, FSIR discusses the 5 P’s of MSK interventions and the importance of remembering the mnemonic device “Prior Planning Prevents Poor Performance.” | Read More
Transcatheter arterial chemoembolization (TACE) combined with apatinib prolonged time to progression and overall survival compared to TACE-alone for Barcelona Clinic Liver Cancer stage C HCC, according to a study published in BMC Cancer. | Read More
Long-term survival in patients with massive hepatocellular carcinomas was improved when treatment consisted of transcatheter arterial chemoembolization (TACE) combined with percutaneous microwave coagulation therapy compared with TACE alone. | Read More
Ablation and stereotactic body radiation therapy are both effective treatments for patients with hepatocellular carcinoma, especially those in early stages of the disease. Siddharth A. Padia, MD explains what interventional radiologists need to know when deciding between ablation and SBRT for HCC. | Read More

Spotlight

In this video, Sean M. Tutton, MD, FSIR discusses the 5 P’s of MSK interventions and the importance of remembering the mnemonic device “Prior Planning Prevents Poor Performance.”
Ablation and stereotactic body radiation therapy are both effective treatments for patients with hepatocellular carcinoma, especially those in early stages of the disease. Siddharth A. Padia, MD explains what interventional radiologists need to know when deciding between ablation and SBRT for HCC.
In this video, Matthew Callstrom, MD, PhD discusses the risk of collecting system injury with microwave ablation and how central renal tumors can be effectively treated.